| ▲ | giardini 3 days ago | |
They don't say what is injected, calling it only a "gerozyme inhibitor". Original article appears to be: https://www.science.org/doi/10.1126/science.adx6649 Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration Mamta Singla https://orcid.org/0000-0002-6408-1167, Yu Xin Wang https://orcid.org/0000-0001-8440-9388, Elena Monti https://orcid.org/0000-0002-3767-0855, Yudhishtar Bedi https://orcid.org/0000-0002-1213-4116, [...] , and Nidhi Bhutani https://orcid.org/0000-0002-7494-5870 FTFA: "Both systemic and local inhibition of 15-PGDH with a small molecule inhibitor (PGDHi) led to regeneration of articular cartilage and reduction in OA-associated pain." "PGDHi" is a name for both the process "15-hydroxyprostaglandin dehydrogenase inhibition" and any inhibitor. This link(a PDF file) shows PGDHi's are powerful stuff: https://www.biorxiv.org/content/biorxiv/early/2025/04/17/202... "PGDHi" could be prostaglandin-E2 (dinoprostone): https://en.wikipedia.org/wiki/Prostaglandin_E2 which was used in: https://med.stanford.edu/news/all-news/2025/06/muscle-aging.... | ||